News
BMRA
0.9277
+4.24%
0.0377
Weekly Report: what happened at BMRA last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at BMRA last week (0311-0315)?
Weekly Report · 03/18 12:05
Weekly Report: what happened at BMRA last week (0304-0308)?
Weekly Report · 03/11 12:00
Weekly Report: what happened at BMRA last week (0226-0301)?
Weekly Report · 03/04 12:03
12 Health Care Stocks Moving In Friday's After-Market Session
Ainos (NASDAQ:AIMD) stock moved upwards by 54.3% to $1.62 during Friday's after-market session. Aadi Bioscience and Taysha Gene Therapies stock also rose during the session. Losers Healthcare Triangle stock fell 8.1% during the same time period.
Benzinga · 03/01 21:32
12 Health Care Stocks Moving In Thursday's After-Market Session
Cardiff Oncology (NASDAQ:CRDF) shares moved upwards by 28.6% to $2.27 during Thursday's after-market session. The company's, Q4 earnings came out today. Burning Rock Biotech stock rose 10.84% and Kineta shares increased by 20.6%.
Benzinga · 02/29 21:31
Weekly Report: what happened at BMRA last week (0219-0223)?
Weekly Report · 02/26 12:22
Press Release: Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board Mr. Huff was the Former CEO of LabCorp Diagnostics and joins with significant executive experience and a proven track record in medical diagnostics and healthcare. Huff brings extensive expertise to drive expansion of the inFoods IBS product.
Dow Jones · 02/21 13:19
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
Biomerica, Inc. Announces appointment of Gary Huff to its Strategic Advisory Board. Huff is the former CEO of Diagnostics at Laboratory Corporation of America Holdings. Huff brings extensive expertise to Biomerica. Huff will help drive expansion of the inFoods® IBS product.
Barchart · 02/21 07:19
Weekly Report: what happened at BMRA last week (0212-0216)?
Weekly Report · 02/19 12:25
Biomerica Inc: [Amend]Statement of acquisition of beneficial ownership by individuals
Press release · 02/14 18:04
Weekly Report: what happened at BMRA last week (0205-0209)?
Weekly Report · 02/12 12:10
Biomerica Has Received A Decision To Grant European Patent Number EP3449254 Titled "Compositions, Devices, And Methods Of Crohn's Disease Sensitivity Testing"
Benzinga · 02/07 18:37
Weekly Report: what happened at BMRA last week (0129-0202)?
Weekly Report · 02/05 12:23
Weekly Report: what happened at BMRA last week (0122-0126)?
Weekly Report · 01/29 12:05
Biomerica Appoints Jack Kenny As Chairman Of The Board
Jack Kenny most recently served as CEO of Meridian Bioscience where he built and managed the sale of the company for $1.53 billion. Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcare. Zack Irani, CEO of Biomerica will continue to serve as CEO.
Benzinga · 01/23 13:29
Press Release: Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica
Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica. Kenny most recently served as CEO of Meridian Bioscience where he built and managed the sale of the company for $1.53 billion. Mr. Kenny has significant executive experience and a proven track record in medical diagnostics.
Dow Jones · 01/23 13:19
Weekly Report: what happened at BMRA last week (0115-0119)?
Weekly Report · 01/22 12:12
Biomerica reports Q2 results
Seeking Alpha · 01/16 21:48
BMRA Stock Earnings: Biomerica Reported Results for Q2 2024
Biomerica reported earnings per share of -9 cents. The company reported revenue of $1.57 million. Biomerica is down 7% to $2.05 per share on the day of the report. The stock is down 10% in the past week.
Investorplace · 01/16 19:51
More
Webull provides a variety of real-time BMRA stock news. You can receive the latest news about Biomerica Inc through multiple platforms. This information may help you make smarter investment decisions.
About BMRA
Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. It is also engaged in the research, development, commercialization and in certain cases regulatory approval, of patented, diagnostic-guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases. The Company's InFoods IBS product uses a simple blood sample and is designed to identify patient-specific foods that, when removed from the diet, may alleviate IBS symptoms such as pain, bloating, diarrhea and constipation. The Company’s two subsidiaries, Biomerica de Mexico, which is used for assembly/manufacturing and BioEurope GmbH, which acts as a distributor of Biomerica products in certain markets.